Literature DB >> 16790202

[Coronary angiography: beyond coronary anatomy].

Armando Pérez de Prado1, Felipe Fernández-Vázquez, J Carlos Cuellas-Ramón, C Michael Gibson.   

Abstract

Although technical advances enable normal epicardial coronary artery blood flow to be restored in most patients suffering myocardial infarction, restoration of blood flow is not always followed by improved myocardial perfusion. Recently, therefore, interest in the assessment of myocardial perfusion has grown, and a number of different assessment methods are available. The aim of this article was to provide an evaluation of the additional information that can be obtained from the widely used technique of conventional coronary angiography. We present a review of the data on epicardial coronary artery blood flow (both semiquantitative and quantitative) and on microvascular blood flow that can be obtained using coronary angiography and discuss their prognostic significance.

Entities:  

Mesh:

Year:  2006        PMID: 16790202

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  3 in total

1.  The never ending quest for an ideal angiographic surrogate of coronary reperfusion.

Authors:  Vijayakumar Subban; Ajit S Mullasari
Journal:  Indian Heart J       Date:  2012-12-26

2.  Author's reply.

Authors:  İsmail Erden; Yasin Türker
Journal:  Anatol J Cardiol       Date:  2015-06       Impact factor: 1.596

3.  Accuracy of Post-thrombolysis ST-segment Reduction as an Adequate Reperfusion Predictor in the Pharmaco-Invasive Approach.

Authors:  Henrique Tria Bianco; Rui Povoa; Maria Cristina Izar; Braulio Luna Filho; Flavio Tocci Moreira; Edson Stefanini; Henrique Andrade Fonseca; Adriano Henrique Pereira Barbosa; Claudia Maria Rodrigues Alves; Adriano Mendes Caixeta; Iran Gonçalves; Pedro Ivo de Marqui Moraes; Renato Delascio Lopes; Angelo Amato Vincenzo de Paola; Dirceu Almeida; Valdir Ambrosio Moises; Francisco A H Fonseca
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.